QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
Log in
ASX:BGT

Bio-Gene Technology Competitors

Add
Compare
Today's Range N/A
50-Day Range
A$0.19
MA: A$0.19
A$0.19
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Bio-Gene Technology (ASX:BGT) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying BGT stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Bio-Gene Technology, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

(CHV) (CNSX:CHV) and Bio-Gene Technology (ASX:BGT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, dividends, earnings and analyst recommendations.

Analyst Recommendations

This is a summary of current ratings for (CHV) and Bio-Gene Technology, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Bio-Gene Technology0000N/A

Profitability

This table compares (CHV) and Bio-Gene Technology's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
Bio-Gene TechnologyN/AN/AN/A

Earnings and Valuation

This table compares (CHV) and Bio-Gene Technology's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Bio-Gene Technology$82,795.000.00$-2,577,370.00A($0.02)N/A

(CHV) has higher earnings, but lower revenue than Bio-Gene Technology.

Summary

Bio-Gene Technology beats (CHV) on 1 of the 1 factors compared between the two stocks.

Bio-Gene Technology (ASX:BGT) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Analyst Recommendations

This is a summary of recent recommendations for Bio-Gene Technology and (DDXS), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Gene Technology0000N/A
(DDXS)0000N/A

Earnings & Valuation

This table compares Bio-Gene Technology and (DDXS)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Gene Technology$82,795.000.00$-2,577,370.00A($0.02)N/A
(DDXS)N/AN/AN/AN/AN/A

(DDXS) has lower revenue, but higher earnings than Bio-Gene Technology.

Profitability

This table compares Bio-Gene Technology and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Gene TechnologyN/AN/AN/A
(DDXS)N/AN/AN/A

Summary

Bio-Gene Technology beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Bio-Gene Technology (ASX:BGT) and (PREV) (CNSX:PREV) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Profitability

This table compares Bio-Gene Technology and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Gene TechnologyN/AN/AN/A
(PREV)N/AN/AN/A

Valuation and Earnings

This table compares Bio-Gene Technology and (PREV)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Gene Technology$82,795.000.00$-2,577,370.00A($0.02)N/A
(PREV)N/AN/AN/AN/AN/A

(PREV) has lower revenue, but higher earnings than Bio-Gene Technology.

Analyst Ratings

This is a summary of current ratings and price targets for Bio-Gene Technology and (PREV), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Gene Technology0000N/A
(PREV)0000N/A

Summary

Bio-Gene Technology beats (PREV) on 1 of the 1 factors compared between the two stocks.

Bio-Gene Technology (ASX:BGT) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership and risk.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Bio-Gene Technology and (TNGN), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Gene Technology0000N/A
(TNGN)0000N/A

Earnings & Valuation

This table compares Bio-Gene Technology and (TNGN)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Gene Technology$82,795.000.00$-2,577,370.00A($0.02)N/A
(TNGN)N/AN/AN/AN/AN/A

(TNGN) has lower revenue, but higher earnings than Bio-Gene Technology.

Profitability

This table compares Bio-Gene Technology and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Gene TechnologyN/AN/AN/A
(TNGN)N/AN/AN/A

Summary

Bio-Gene Technology beats (TNGN) on 1 of the 1 factors compared between the two stocks.

138267 (COM.TO) (TSE:COM) and Bio-Gene Technology (ASX:BGT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation.

Analyst Recommendations

This is a breakdown of current ratings for 138267 (COM.TO) and Bio-Gene Technology, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
Bio-Gene Technology0000N/A

Earnings and Valuation

This table compares 138267 (COM.TO) and Bio-Gene Technology's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
Bio-Gene Technology$82,795.000.00$-2,577,370.00A($0.02)N/A

138267 (COM.TO) has higher earnings, but lower revenue than Bio-Gene Technology.

Profitability

This table compares 138267 (COM.TO) and Bio-Gene Technology's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
Bio-Gene TechnologyN/AN/AN/A

Summary

Bio-Gene Technology beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

17031 (CNSX:MYM) and Bio-Gene Technology (ASX:BGT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for 17031 and Bio-Gene Technology, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
170310000N/A
Bio-Gene Technology0000N/A

Profitability

This table compares 17031 and Bio-Gene Technology's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
17031N/AN/AN/A
Bio-Gene TechnologyN/AN/AN/A

Earnings & Valuation

This table compares 17031 and Bio-Gene Technology's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
17031N/AN/AN/AN/AN/A
Bio-Gene Technology$82,795.000.00$-2,577,370.00A($0.02)N/A

17031 has higher earnings, but lower revenue than Bio-Gene Technology.

Summary

Bio-Gene Technology beats 17031 on 1 of the 1 factors compared between the two stocks.


Bio-Gene Technology Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5$2.95flatC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00
Abzena plc (ABZA.L) logo
ABZA
Abzena plc (ABZA.L)
0.6$15.75flat£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.61 million0.00High Trading Volume
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$2.84 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.5N/AN/A$0.00$4.23 million0.00High Trading Volume
Gap Up
ADTX
ADiTx Therapeutics
1.0$2.84flat$0.00N/A0.00Decrease in Short Interest
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
AGNPF
Algernon Pharmaceuticals
0.0$0.24flat$0.00N/A0.00
Almirall logo
LBTSF
Almirall
0.5$12.40flat$0.00N/A0.00
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANR
Anatara Lifesciences
0.5N/AN/A$0.00$268,259.000.00High Trading Volume
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
CBDC
Apotheca Biosciences
0.4$0.05flat$0.00N/A0.00Gap Up
ARNI
Arno Therapeutics
0.5$0.00flat$0.00N/A0.00News Coverage
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00News Coverage
CDMOP
Avid Bioservices
0.3$29.66flat$0.00N/A0.00Dividend Announcement
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.57flat$0.00N/A0.00News Coverage
Gap Down
BXRXV
Baudax Bio
0.5$4.51flat$0.00N/A0.00High Trading Volume
News Coverage
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00Analyst Report
News Coverage
BNO
Bionomics Limited (BNO.AX)
0.5N/AN/A$0.00$3.19 million0.00High Trading Volume
Gap Up
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.18 million0.00High Trading Volume
Gap Up
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$7.56 million0.00High Trading Volume
News Coverage
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$100,744.000.00High Trading Volume
Gap Up
BTC
BTC Health
0.8N/AN/A$0.00$131,934.000.00High Trading Volume
Gap Up
CNBX
Cannabics Pharmaceuticals
0.4$0.35flat$0.00N/A0.00Gap Down
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid Limited (CDY.AX)
0.8N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
CBBT
Cerebain Biotech
0.0$0.09flat$0.00N/A0.00Increase in Short Interest
Gap Up
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$17.20flat$0.00N/A0.00
CUV
Clinuvel Pharmaceuticals
1.0N/AN/A$0.00$38.34 million0.00High Trading Volume
Gap Up
CELZ
Creative Medical Technology
0.5$0.04flat$0.00N/A0.00Gap Down
CSL logo
CSL
CSL
0.8N/AN/A$0.00$9.98 billion0.00High Trading Volume
News Coverage
Gap Up
CLXPF
Cybin
1.0$1.15flat$0.00N/A0.00Gap Up
CYP
Cynata Therapeutics
0.5N/AN/A$0.00$2.59 million0.00High Trading Volume
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00News Coverage
Gap Down
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.43flat$0.00N/A0.00Gap Down
EX1
Exopharm
0.6N/AN/A$0.00$2.72 million0.00High Trading Volume
Gap Up
FTT
Factor Therapeutics
0.5N/AN/A$0.00$667,611.000.00High Trading Volume
This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.